Eli Lilly and Company
Eli Lilly and Company logo
LLY

Eli Lilly and Company (LLY)

$342.11.7%

Market is closed
– opens on 8 PM, 30 Jan 2023
  • $

1D

1W

1M

1Y

3Y

5Y

What's happening with Eli Lilly and Company

  • Eli Lilly and Company is trending in news

    29-Jan-2023

    Eli Lilly share price eased despite receiving the US FDA approval for its blood cancer drug.

Key Stats

$341.66
Day's Range
$347.78
$229.7
52-Week Range
$384.44
1 month return6.79%
3 month return5.52%
1 year return39.41%
5 year return290.53%

Insights on Eli Lilly and Company

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 6.48B → 6.94B (in $), with an average increase of 6.5% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 952.5M → 1.45B (in $), with an average increase of 34.4% per quarter

Analyst Recommendation

based on 29 analysts ratings

Buy
75%
Buy
24%
Hold
0%
Sell

Based on 29 Wall street analysts offering stock ratings for Eli Lilly and Company(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 13.87%

Current

$342.1

Target

$389.56

Recommendation Trend

Based on 29 analyst

Current1M Ago3M Ago
Buy
22
14
21
Hold
7
8
7
Sell
0
1
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization325.1B
Book Value$11.19
Dividend Share3.79
Dividend Yield1.3%
Earnings Per Share (EPS)6.65
PE Ratio51.44
PEG Ratio2.18
Wall Street Target Price389.56

Valuation

Trailing PE51.44
Forward PE39.06
Price/Book (mrq)34.06
Enterprise Value356.2B
Enterprise Value/Revenue12.18
Enterprise Value/Ebitda42.04

Technicals

Beta0.38
50 Day MA360.73
200 Day MA327.25

Sustainability

Rating Date2019-01-01
Total Esg32.36
Total Esg Percentile70.22
Environment Score0.63
Environment Score Percentile1.0
Social Score16.68
Social Score Percentile1.0
Governance Score13.31
GovernanceScorePercentile1.0
Controversy Level3.0

Institutional Holdings

Lilly Endowment Inc

10.92%

Vanguard Group Inc

7.64%

BlackRock Inc

6.67%

PNC Financial Services Group Inc

5.48%

State Street Corporation

3.53%

FMR Inc

3.48%

Company Information

Lilly (Eli) & Co. is an American-based multinational pharma company with offices in 18 countries. Its headquarters are situated in Indianapolis, Indiana, and it sells drugs in over 125 countries. Colonel Eli Lilly was a pharmaceutical chemist and American Civil War veteran who founded this company in 1876. It is traded as LLY in the New York Stock Exchange (NYSE). Lilly employs over 33,000 people and generated a revenue of over 22 billion USD as of 2019. The company is committed to researching and developing high-quality drugs for humankind's welfare by remaining true to its work. In 1876, this company produced the medicinal drug called quinine used in the treatment of Malaria. Among its many commendable innovations were gelatin-coating for the capsules & pills and sugar-coated pills that make them easier to swallow. It also developed various drugs for treating syphilis, rheumatism, eczema, and psoriasis in the early 1880s. A scientific journal asserted that the Lilly operation was the largest capsule factory in the world in 1917. In 1923, Lilly mass-produced the Insulin under the name “Iletin” used to treat diabetes in the US. Moreover, it also became the company to mass-produce Penicillin in the 1940s and started producing the Polio vaccine in the early 1950s. It acquired CoLucid in 20017 for 960mn USD and Armo Biosciences for 1.6bn USD in 2018. Also, it purchased the Aurora Kinase A, an inhibitor developer, for 575mn USD. It acquired multiple companies for developing and researching breakthroughs. The company aims to bring life-changing research to the community while performing voluntary & philanthropist operations worldwide. Currently Lilly(Eli) & Co has a market cap of $330.67 Billion. It has a P.E ratio of 54.81. The shares of Lilly(Eli) & Co are trading at $342.1. .
OrganizationEli Lilly and Company
Employees35000
CEOMr. David A. Ricks
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is Eli Lilly and Company share price today?

Can Indians buy Eli Lilly and Company shares?

How can I buy Eli Lilly and Company shares from India?

Can Fractional shares of Eli Lilly and Company be purchased?

What are the documents required to start investing in Eli Lilly and Company stocks?

What are today’s High and Low prices of Eli Lilly and Company?

What are today’s traded volumes of Eli Lilly and Company?

What is today’s market capitalisation of Eli Lilly and Company?

What is the 52 Week High and Low Range of Eli Lilly and Company?

How much percentage Eli Lilly and Company is down from its 52 Week High?

How much percentage Eli Lilly and Company is up from its 52 Week low?

What are the historical returns of Eli Lilly and Company?

Who is the Chief Executive Officer (CEO) of Eli Lilly and Company?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*